Financials disclosed in this offering
FY2023–FY2024 · hover for sourceThe fiscal years the issuer disclosed in this offering’s filing, as filed. Full history on the company page.
Amendments to this offering
2 amendments- Nov 24, 2025
- Deadline Nov 24, 2025 → Mar 25, 2026
“Extending campaign end date to March 25, 2026 and campaign page edits”
Form C/A on EDGAR ↗ - Sep 24, 2025
- Deadline Sep 24, 2025 → Nov 24, 2025
“Added transition update Qube Checking pause/Qube+, clarified interim features and near term revenue mix, revised runway breakeven to conditional, added consolidated risk and forward looking statements updates; extended deadline.”
Form C/A on EDGAR ↗
Each line compares the amendment with the previous filing of this offering. The quoted reason is the issuer’s own statement from the Form C/A.
Deal terms
Perks
Offering details
Links & provenance
0001665160-25-001249
Last synced Aug 18, 2026
About this data. Raised amounts and investor counts come from the platform listing and may lag or be restated; SEC-reported totals can differ until the next Form 1-Z/C-U. Post-money valuation is computed as pre-money plus amount raised and is shown once the round closes — it is not a traded price. Financial statements are as reported by the issuer. Crowdonomics is not a broker-dealer, funding portal, or investment adviser; nothing here is investment advice or an offer to sell securities. Verify all figures against the linked EDGAR filings.